Standard BioTools
LAB
LAB
135 hedge funds and large institutions have $864M invested in Standard BioTools in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $854M → $864M (+$10.1M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
97% less call options, than puts
Call options by funds: $6K | Put options by funds: $196K
Holders
135
Holding in Top 10
1
Calls
$6K
Puts
$196K
Top Buyers
| 1 | +$28.3M | |
| 2 | +$21.1M | |
| 3 | +$18.4M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$13.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.88M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$10.3M | |
| 3 | -$8.99M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$6.85M |
| 5 |
D.E. Shaw & Co
New York
|
-$4.74M |